Widad Group reiterates plan to sell oral-based Covid-19 vaccine in Malaysia theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.
17 Dec 2020 / 21:35 H. Pix for representational purpose only.
KUALA LUMPUR: Widad Group Bhd has clarified that the rationale for its memorandum of collaboration with Rinani Dynamic Sdn Bhd inked on Dec 15 is to distribute, market and sell oral-based Covid-19 vaccine named VXA-Cov2-1 in Malaysia.
Rinani Dynamic is the local representative for Vaxart Inc, a US-based company that manufactures the vaccine and other products.
VXA-CoV2-1 is a single-dose Covid-19 tablet vaccine that Vaxart Inc says can be distributed conveniently without the need for cold-chain storage and distribution.
Widad Group managing director Datuk Mohd Rizal Mohd Jaafar said the company, which is principally involved in construction activities and integrated facilities management services, has not approached any potential customers yet as the vaccine is still undergoing clinical trials.